IntelliPharmaCeutics International (IPCIQ) Stock Statistics & Valuation Metrics
Total Valuation
IntelliPharmaCeutics International has a market cap or net worth of $2.38M. The enterprise value is ―.
- Market Cap
- $2.38M
- Enterprise Value
- ―
Share Statistics
IntelliPharmaCeutics International has 35,002,666 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 35,002,666
- Owned by Insiders
- ―
- Owned by Institutions
- 5.56%
Financial Efficiency
IntelliPharmaCeutics International’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
- Return on Equity (ROE)
- ―
- Return on Assets (ROA)
- ―
- Return on Invested Capital (ROIC)
- ―
- Return on Capital Employed (ROCE)
- ―
- Revenue Per Employee
- ―
- Profits Per Employee
- -922.14K
- Employee Count
- 11
- Asset Turnover
- ―
- Inventory Turnover
- ―
Income Statement
In the last 12 months, IntelliPharmaCeutics International had revenue of ― and earned -10.14M in profits. Earnings per share was ―.
- Revenue
- ―
- Gross Profit
- 2.25M
- Operating Income
- -9.85M
- Pretax Income
- ―
- Net Income
- -10.14M
- EBITDA
- -9.49M
- Earnings Per Share (EPS)
- ―
Stock Price Statistics
- Beta
- 0.00
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.15
- 200-Day Moving Average
- 0.15
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
IntelliPharmaCeutics International upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Apr 21, 2025
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Balance Sheet
IntelliPharmaCeutics International has ― in cash and marketable securities with $1.93M in debt, giving a net cash position of ― billion.
- Cash & Marketable Securities
- ―
- Total Debt
- $1.93M
- Net Cash
- ―
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- ―